Table 2 |
|||
|
Clinical factors by HER2/neu status |
|||
| Clinical factors |
HER2/neu negative |
HER2/neu positive |
P valuea |
|
|
|||
| T stage |
|||
| T1 |
29 |
10 |
|
| T2/3 |
49 |
16 |
NS |
| N stage |
|||
| N0 |
50 |
15 |
|
| N1 |
28 |
14 |
NS |
| Age (years) |
50.2 ± 11.3 |
50.8 ± 12.6 |
NS |
|
|
|||
|
aχ2 test and Student's t-test. HER, human epidermal growth factor receptor; NS, not significant. |
|||
|
Sunami et al. Breast Cancer Research 2008 10:R46 doi:10.1186/bcr2098 |
|||
